metastatic NCSLC initially treated with CRT (carbo/taxol), SRT to brain lesion followed by 2 cycles of carbo/taxol consolidation. F/u scans showed progression of disease. Received WBRT. There is no evidence of intracranial hemorrhage, mass, or acute infarct. There is unchanged confluent cerebral white matter T2 hyperintensity. There is no abnormal intracranial enhancement. The ventricles and basal cisterns are unchanged in size and configuration. There is no midline shift or herniation. The major cerebral flow voids are intact. The orbits, skull, paranasal sinuses, and scalp soft tissues are unremarkable.
Post-treatment findings in the brain without evidence of recurrent brain metastatic disease. 